Skip to main content

Table 2 Overview of microglial subtypes markers and features

From: Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases

Type of immune cell

Markers

Promoting factors

Inhibitory factors

Primary function

Condition explored

WAM

Apoe, CD63, Clec7a, TMEM119, CX3CR1, P2RY12,Csf1r [195]

TREM2-dependent-ApoE-independent [196, 197]

CSF1R suppressor [198]

Generates proinflammatory cytokines and display reduced phagocytic activity [196, 199], WAM are precursors to DAM and function in the removal of myelin debris [21, 196]

Aged brain, AD [196]

DAM

Lpl, ApoE, TMEM119, P2RY12, CX3CR1, TREM2, CST7, and Axl [200, 201]

Protein accumulation, apoptotic cells, and myelin debris, and needs signaling via type I interferons (IFN-α and IFN-β (IFN-α/β)) and type II interferon (IFN-γ) [200]

TGF-β and NRROS [202]

DAMs reduce the transcriptional signature exclusive to microglia and enhance IFN-feedback genes, lysosomal genes, genes that code lipid-metabolism elements and further exterior receptors and elements related to the damage of synapses and nerve cells [200]

Aged brain, AD [203], PD [204], ALS [205]

LDAM

RAP1B, RAK1, CHBB, TLR2/4, IFN-γ receptor [88]

TREM2-ApoE pathway, phagosome development, innate inflammation [88], generation of nitric oxide and ROS [206]

Triacsin C [88]

LDAMs are deficient in phagocytosis, generate proinflammatory cytokines [88] and synthesize prominent levels of ROS [206]

Aged brain, AD [51], ALS [207]

MGnD

Clec7a, Lgals3, Gpnmb, Itgax, app1, Fabp5, Ccl2 [208]

Apoptotic nerve cells, relies on the TREM2-APOE pathway [208]

Relies on the TREM2-APOE signaling [208]

This type of microglia loses sensome actions such as TGFβ signaling[209], MGnD microglia might also be protective and constitute an initial reply to nerve cells damage [210]

Aged brain, neuritic dystrophy, AD, MS, ALS [208]

  1. TMEM119 transmembrane protein 119, P2RY12 P2Y purinoceptor 12, SALL1 Sal-like protein 1, CX3CR1 CX3C chemokine receptor 1, IBA1 ionized calcium-binding adaptor molecule 1, TREM2 triggering receptor expressed on myeloid cells 2, LYVE1 lymphatic vessel endothelial hyaluronan receptor 1, CCR2 C–C chemokine receptor 2, P2RY12 purinergic P2 receptors Y12, Tmem119 transmembrane protein 119, Siglech sialic acid-binding Ig-like lectin H, Gpr34 probable G protein-coupled receptor 34, MGnD microglial neurodegenerative phenotype, LDAM lipid-droplet-accumulating microglia, WAM white matter-associated microglia, DAM disease-associated microglia